# Institute of Human Virology Annual Meeting 2016-2021

> **NIH NIH R13** · UNIVERSITY OF MARYLAND BALTIMORE · 2021 · $30,000

## Abstract

PROJECT SUMMARY
The Annual International Meeting of the Institute of Human Virology began at the National Cancer Institute
in the mid-1970s and brings together the world's foremost experts on the biology of HIV/AIDS, particularly
on basic and vaccine science and new treatment and prevention approaches. The five specific aims of this
conference are to disseminate the most current research findings within the selected program topics; critically
assess the impact of new findings on future directions for research; provide a forum for discussion of current
and emerging issues; identify, support, and build the next generation AIDS researcher; and increase
participation by women, ethnic/racial minorities, and other individuals traditionally underrepresented in science.
In 2013, the meeting was moved to Moscow, Russian Federation and co-sponsored with the Moscow Center
for HIV Treatment and Prevention. This significant change of venue recognized the importance of viral
diseases, including HIV/AIDS, in the Russian Federation, Europe, and Asia, and opened up new avenues of
collaboration in basic research, diagnosis, prevention, and treatment of human viral diseases among these
geographic centers. The event returned to Baltimore in 2014 carrying forth the tradition of in-depth science
at the cutting edge of new discovery, and in 2015 offered sessions on mechanisms of viral latency and recent
advances in understanding the barriers to an HIV cure. Last year's meeting also included a special session
on global virus threats: translating basic science to public health practice, while focus also continued on
structural biology, immunology, and vaccines, and discussions on HIV co-infections/co-morbidities were
expanded to included hepatitis C as well as cancer. Meeting sessions are customarily organized with
divergent perspectives and ethnically diverse participants and are interspersed with special lectures designed
to introduce new disciplines to discussions. Conference results are shared with the broader scientific community
through publication of all speaker and poster abstracts in meeting materials and online. In 2016, the 18th
Annual International Meeting is scheduled for Sep 19-22 in Baltimore, MD, with 400 participants
anticipated, including significant NIH representation. Thematic sessions will include: Advances in
Clinical Virology; Immunology and Immunopathogenesis; Viral Structure and Biology; HIV Cure
Research; Progress in Vaccinology; Infectious Agents in Lymphoma and Cancer; and a Global Update.
Posters will be displayed throughout the 4-day meeting, with evening activities designed to engage
participants with collaborators, build new scientific partnerships, and foster the next generation of HIV/AIDS
researcher with podium presentation of selected abstracts by young investigators. As is the tradition, a
scholarship initiative will offer women, minorities, and other typically under-represented populations with the
opportunity to participate for very...

## Key facts

- **NIH application ID:** 9981608
- **Project number:** 5R13AI046078-21
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** ROBERT C GALLO
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $30,000
- **Award type:** 5
- **Project period:** 1999-08-18 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9981608

## Citation

> US National Institutes of Health, RePORTER application 9981608, Institute of Human Virology Annual Meeting 2016-2021 (5R13AI046078-21). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9981608. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*